CD4 and myeloid sarcoma: A paired Wilcoxon test comparing T cell responses to VZV and EBV revealed higher proliferation after stimulation of CD4+ T cells from REM-MS patients and HC with VZV (p = 0.039 and p = 0.016, respectively) (Figure 3D,E).